β-Adrenergic receptor inhibition affects cerebral glucose metabolism, motor performance, and inflammatory response after traumatic brain injury

Journal of Trauma and Acute Care Surgery

Volumn 73, Issue 1, 2012, Pages 33-40

  Ley, Eric J ^a   Clond, Morgan A ^a   Bukur, Marko ^a   Park, Ryan ^b   Chervonski, Michael ^b   Dagliyan, Grant ^b   Margulies, Dan R ^a   Lyden, Patrick D ^a   Conti, Peter S ^b   Salim, Ali ^a  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Traumatic brain injury; A adrenergic receptor; cerebral glucose metabolism; propranolol; knockout.

Indexed keywords

BETA 1 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR; FLUORODEOXYGLUCOSE F 18; GLUCOSE; HEAT SHOCK PROTEIN 70; INTERLEUKIN 1BETA; INTERLEUKIN 6; PROPRANOLOL;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BETA ADRENERGIC RECEPTOR BLOCKING; BRAIN METABOLISM; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; GLUCOSE BRAIN LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INFLAMMATION; MALE; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; MOUSE STRAIN; NONHUMAN; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; PROTEIN EXPRESSION; ROTAROD TEST; TRAUMATIC BRAIN INJURY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; BLOTTING, WESTERN; BRAIN; BRAIN CHEMISTRY; BRAIN INJURIES; GLUCOSE; HSP70 HEAT-SHOCK PROTEINS; INFLAMMATION; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MOTOR SKILLS; PROPRANOLOL; RECEPTORS, ADRENERGIC, BETA;

EID: 84864249905     PISSN: 21630755     EISSN: 21630763     Source Type: Journal    
DOI: 10.1097/TA.0b013e31825a769b     Document Type: Article

References (40)

1. Faul M, Xu L, Wald MM, Coronado VG. Traumatic Brain Injury in the United States: Emergency Department Visits, Hospitalizations, and Deaths. Atlanta, GA: Centers for Disease Control and Prevention, National Center for Injury Prevention and Control; 2010.
2. Centers for Disease Control and Prevention (CDC), National Center for Injury Prevention and Control. Report to Congress on Mild Traumatic Brain Injury in the United States: Steps to Prevent a Serious Public Health Problem. Atlanta, GA: Centers for Disease Control and Prevention; 2003.
3. Koponen S, Taiminen T, Portin R, Himanen L, Isoniemi H, Heinonen H, Hinkka S, Tenovuo O. Axis I and II psychiatric disorders after traumatic brain injury: a 30-year follow-up study. Am J Psychiatry. 2002;159: 1315Y1321.
4. Schönberger M, Ponsford J, Gould KR, Johnston L. The temporal relationship between depression, anxiety, and functional status after traumatic brain injury: a cross-lagged analysis. J Int Neuropsychol Soc. 2011;17:781Y787.
5. Goldman SM, Tanner CM, Oakes D, Bhudhikanok GS, Gupta A, Langston JW. Head injury and Parkinson's disease risk in twins. Ann Neurol. 2006;60:65Y72.
6. Ley EJ, Scehnet J, Park R, Schroff S, Dagliyan G, Conti PS, Margulies DR, Salim A. The in vivo effect of propranolol on cerebral perfusion and hypoxia after traumatic brain injury. J Trauma. 2009;66:154Y161.
7. Ley EJ, Park R, Dagliyan G, Palestrant D, Miller CM, Conti PS, Margulies DR, Salim A. In vivo effect of propranolol dose and timing on cerebral perfusion after traumatic brain injury. J Trauma. 2010;68:353Y356.
8. Cotton BA, Snodgrass KB, Fleming SB, Carpenter RO, Kemp CD, Arbogast PG, Morris JA. Beta-blocker exposure is associated with improved survival after severe traumatic brain injury. J Trauma. 2007;62:26Y35.
9. Inaba K, Teixeira PG, David JS, Chan LS, Salim A, Brown C, Browder T, Beale E, Rhee P, Demetriades D. Beta-blockers in isolated blunt head injury. J Am Coll Surg. 2008;206:432Y438.
10. Heffernan DS, Inaba K, Arbabi S, Cotton BA. Sympathetic hyperactivity after traumatic brain injury and the role of beta-blocker therapy. J Trauma. 2010;69:1602Y1609.
11. Chen-Izu Y, Xiao RP, Izu LT, Cheng H, Kuschel M, Spurgeon H, Lakatta EG. G(i)-dependent localization of beta(2)-adrenergic receptor signaling to L-type Ca2+ channels. Biophys J. 2000;79:2547Y2556.
12. Akaike N, Nishi K, Oyama Y. Inhibitory effects of propranolol on the calcium current of Helix neurones. Br J Pharmacol. 1981;73:431.
13. Chioléro RL, Breitenstein E, Thorin D, Christin L, de Tribolet N, Freeman J, Jéquier E, Schutz Y. Effects of propranolol on resting metabolic rate after severe head injury. Crit Care Med. 1989;17:328Y334.
14. Laureys G, Clinckers R, Gerlo S, Spooren A, Wilczak N, Kooijman R, Smolders I, Michotte Y, De Keyser J. Astrocytic beta(2)-adrenergic receptors: from physiology to pathology. Prog Neurobiol. 2010;91:189Y199.
15. Nilsson P, Hillered L, Pontén U, Ungerstedt U. Changes in cortical extracellular levels of energy-related metabolites and amino acids following concussive brain injury in rats. J Cereb Blood Flow Metab. 1990;10:631Y637.
16. Vespa P, Bergsneider M, Hattori N, Wu H-M, Huang S-C, Martin NA, Glenn TC, McArthur DL, Hovda DA. Metabolic crisis without brain ischemia is common after traumatic brain injury: a combined microdialysis and positron emission tomography study. J Cereb Blood Flow Metab. 2005; 25:763Y774.
17. Hyong A, Jadhav V, Lee S, Tong W, Rowe J, Zhang JH, Tang J. Rosiglitazone, a PPAR gamma agonist, attenuates inflammation after surgical brain injury in rodents. Brain Res. 2008;1215:218Y224.
18. Dunn-Meynell AA, Hassanain M, Levin BE. Norepinephrine and traumatic brain injury: a possible role in post-traumatic edema. Brain Res. 1998;800:245Y252.
19. Fonseca RB, Mohr AM, Wang L, Sifri ZC, Rameshwar P, Livingston DH. The impact of a hypercatecholamine state on erythropoiesis following severe injury and the role of IL-6. J Trauma. 2005;59:884Y890.
20. Friese RS, Barber R, McBride D, Bender J, Gentilello LM. Could Beta blockade improve outcome after injury by modulating inflammatory profiles? J Trauma. 2008;64:1061Y1068.
21. Woiciechowsky C, Asadullah K, Nestler D, Eberhardt B, Platzer C, Schöning B, Glöckner F, Lanksch WR, Volk HD, Döcke WD. Sympathetic activation triggers systemic interleukin-10 release in immunodepression induced by brain injury. Nat Med. 1998;4:808Y813.
22. Goldberg MP, Choi DW. Combined oxygen and glucose deprivation in cortical cell culture: calcium-dependent and calcium-independent mechanisms of neuronal injury. J Neurosci. 1993;13:3510.
23. Rosenberg PA. Catecholamine toxicity in cerebral cortex in dissociated cell culture. J Neurosci. 1988;8:2887.
24. Brody DL, Mac Donald C, Kessens CC, Yuede C, Parsadanian M, Spinner M, Kim E, Schwetye KE, Holtzman DM, Bayly PV. Electromagnetic controlled cortical impact device for precise, graded experimental traumatic brain injury. J Neurotrauma. 2007;24:657Y673.
25. Yu S, Kaneko Y, Bae E, Stahl CE, Wang Y, van Loveren H, Sanberg PR, Borlongan CV. Severity of controlled cortical impact traumatic brain injury in rats and mice dictates degree of behavioral deficits. Brain Res. 2009; 1287:157Y163.
26. Lloyd E, Somera-Molina K, Van Eldik LJ,Watterson DM,Wainwright MS. Suppression of acute proinflammatory cytokine and chemokine upregulation by post-injury administration of a novel small molecule improves long-term neurologic outcome in a mouse model of traumatic brain injury. J Neuroinflammation. 2008;5:28.
27. Ley EJ, ClondMA, SingerMB, Shouhed D, Salim A. IL6 deficiency affects function after traumatic brain injury. J Surg Res. 2011;170:253Y256.
28. Mannick JA, Rodrick ML, Lederer JA. The immunologic response to injury. J Am Coll Surg. 2002;194:104Y105.
29. Vink R,NimmoAJ.Multifunctional drugs for head injury. Neurotherapeutics. 2009;6:28Y42
30. Bracken MB. CRASH (Corticosteroid Randomization after Significant Head Injury Trial): Landmark and Storm Warning: landmark and storm warning. Neurosurgery. 2005;57:1300.
31. Pittet JF, Lee H, Morabito D, Howard MB, Welch WJ, Mackersie RC. Serum levels of Hsp 72 measured early after trauma correlate with survival. J Trauma. 2002;52:611.
32. Rainbow TC, Parsons B, Wolfe BB. Quantitative autoradiography of beta 1Y and beta 2Yadrenergic receptors in rat brain. Proc Natl Acad Sci U S A. 1984;81:1585Y1589.
33. Zamah AM, Delahunty M, Luttrell LM, Lefkowitz RJ. Protein kinase amediated phosphorylation of the beta 2Yadrenergic receptor regulates its coupling to Gs and Gi. Demonstration in a reconstituted system. J Biol Chem. 2002;277:31249Y31256.
34. Oberbeck R, Kobbe P. Beta-adrenergic antagonists: indications and potential immunomodulatory side effects in the critically ill. Curr Med Chem. 2009;16:1082Y1090.
35. Beiermeister KA, Keck BM, Sifri ZC, ElHassan IO, Hannoush EJ, Alzate WD, Rameshwar P, Livingston DH, Mohr AM. Hematopoietic progenitor cell mobilization is mediated through beta-2 and beta-3 receptors after injury. J Trauma. 2010;69:338Y343.
36. Wang J, Li J, Sheng X, Zhao H, Cao X-D, Wang Y-Q, Wu G-C. Betaadrenoceptor mediated surgery-induced production of pro-inflammatory cytokines in rat microglia cells. J Neuroimmunol. 2010;223:77Y83.
37. Han R-Q, Ouyang Y-B, Xu L, Agrawal R, Patterson AJ, Giffard RG. Postischemic brain injury is attenuated in mice lacking the beta2- adrenergic receptor. Anesth Analg. 2009;108:280Y287.
38. Yoshino A., Hovda DA, Kawamata T, Katayama Y, Becker DP. Dynamic changes in local cerebral glucose utilization following cerebral concussion in rats: evidence of a hyper- and subsequent hypometabolic state. Brain Res. 1991;561:106Y119.
39. Lee SH, Kwon HM, Kim YJ, Lee KM, Kim M, YoonBW. Effects of hsp70. 1 gene knockout on the mitochondrial apoptotic pathway after focal cerebral ischemia. Stroke. 2004;35:2195.
40. Beere HM, Wolf BB, Cain K, Mosser DD, Mahboubi A, Kuwana T, Tailor P, Morimoto RI, Cohen GM, Green DR. Heat-shock protein 70 inhibits apoptosis by preventing recruitment of procaspase-9 to the Apaf-1 apoptosome. Nat Cell Bio. 2000;2:469Y475.